loading page

Giant Cell Myocarditis Following COVID-19 Successfully Treated by Immunosuppressive Therapy
  • +2
  • Afsaneh Amiri,
  • Golnaz Houshmand,
  • Sepideh Taghavi,
  • Monireh Kamali,
  • Nasim Naderi
Afsaneh Amiri
Rajaie cardiovasular medical and research center,Iran University of medical sciences

Corresponding Author:amiri.afsaneh@yahoo.com

Author Profile
Golnaz Houshmand
Rajaie cardiovascular, medical and research center,Iran University of medical sciences
Author Profile
Sepideh Taghavi
Rajaie cardiovascular medical and research center,Iran University of medical sciences
Author Profile
Monireh Kamali
Iran University of Medical Sciences
Author Profile
Nasim Naderi
Rajaie Cardiovascular Medical and Research Center,Iran university of medical sciences
Author Profile

Abstract

In this case report, we present a 46-year-old lady who has developed a rapidly progressive heart failure after an episode of COVID-19. The pathologic examination of her endomyocardial biopsy specimens was compatible with GCM and she was successfully treated with a combined immunosuppressive therapy regimen.
24 Nov 2021Submitted to Clinical Case Reports
13 Dec 2021Submission Checks Completed
13 Dec 2021Assigned to Editor
22 Dec 2021Reviewer(s) Assigned
22 Dec 2021Review(s) Completed, Editorial Evaluation Pending
20 Jan 2022Editorial Decision: Revise Minor
22 Jan 20221st Revision Received
24 Jan 2022Submission Checks Completed
24 Jan 2022Assigned to Editor
24 Jan 2022Review(s) Completed, Editorial Evaluation Pending
13 Feb 2022Reviewer(s) Assigned
07 Mar 2022Editorial Decision: Accept
Aug 2022Published in Clinical Case Reports volume 10 issue 8. 10.1002/ccr3.6196